2016年10月27日星期四

Dr. Niu Lizhi, the President of Guangzhou Fuda Cancer Hospital visited cancer survivors in Jakarta

On April 11, 2016, Dr. Niu Lizhi, the President of Guangzhou Fuda Cancer Hospital, visited previous cancer patients of Fuda Cancer Hospital in Jakarta after attending ASEAN (International) Forum on Intestine Cancer Treatment in Bali. Affra  Siowardjaja (born in May 6, 1956), who suffered from stage IV breast cancer with bone metastases, have survived 12 years without recurrence after receiving comprehensive treatments that include cryosurgery, chemotherapy and repair surgery, chemotherapy and immunotherapy at FUDA in 2004.

Breast cancer patient Mary Laurensia, born in August 6, 1969, was found to have a breast mass in 2007 but she did not pay any attention to it. In 2008, the mass was found to have grown bigger especially after the pathological examination, which confirmed that she suffered from Stage III breast cancer. She has survived 8 years without recurrence after receiving argon-helium cryosurgery, 6 cycles of chemotherapy, 35 sessions of radiotherapy and endocrine therapy for three years.

Prostate cancer patient Fachrutdin Tjoe, born on August 4, 1947, has survived 7 years without recurrence after receiving argon-helium cryosurgery, interventional chemotherapy in 2009. Oral and liver lymphoma Yana Sari Putri Sihombing, born on January 4, 1079, has survived 7 years without recurrence after receiving argon-helium cryosurgery and chemotherapy at FUDA in 2009. 

Anal canal carcinoma patient Tan Hong Som, born on December 4, 1950, has his anus successfully preserved after receiving PDT (photodynamic therapy), interventional chemotherapy and CIC (combined immunotherapy for cancer) at FUDA instead of going through colostomy in other hospital. Patient has survived 5 years without recurrence and enjoyed high-quality life with the anus in situ since the treatment. 

Pancreatic cancer patient Litasari Karwita, female, 55 years old, has been enjoying a stable condition since treatment three years ago. Kidney cancer patient Henry Widjaja, male, 52 years old, has successfully had his kidney preserved after undergoing argon-helium cryosurgery. 

Advanced uterus cancer patient Yang Chunmei, 80 years old, has survived almost 10 years after going through interventional chemotherapy, photodynamic therapy, argon-helium cryosurgery and immunotherapy at FUDA in 2007. 

Lung cancer patient Dr. Tjan Kian Seng, male, 83 years old, has survived 5 years after undergoing one single cycle of cryosurgery. Liver cancer patient Zhong Guoqing, male, 71 years old, has survived 6 years without recurrence after receiving argon-helium cryosurgery and interventional embolization in early 2010. Some of the above-mentioned patients were not be able to present at the lecture due to private affairs but all of them expressed their appreciation to Dr. Niu Lizhi for coming all the long way to visit them.

Dr. Niu Lizhi noted that cancer is still a world problem. Though new drugs and new technologies are emerging by each passing day, patients cannot make progress on their anti-cancer journey without their own persistence, the encouragement and support from the family members and the rational application of innovative treatments by the doctors. Fuda Cancer Hospital has adopted the latest technology for cancer –NanoKnife, which has proven to be effective in treating pancreatic cancer, liver cancer, etc. During the procedure, high electric-field and ultrashort pulses are given to destroy lipid bilayer structure of cancer cell membrane and form numerous irreversible nano-sized pores in the cell membrane. Tumor cell death is induced while surrounding nerves, blood vessels, intestinal canals, bile duct remain intact. Doctors at FUDA hope to bring about more survival benefits for cancer patients with the latest technology. After met with previous patient, Dr. Niu provided free consultation for new diagnosed cancer patients who come all the long way to him.

                  From left: chief editor Li Zhuohui, breast cancer survivor Mary Laurensia, and Dr. Niu Lizhi
From left: liver cancer survivor Marison Pangadean Siagian, chief editor Li Zhuohui, prostate cancer survivor Fachrutdin Tjoe, Dr. Liu Zhengping

2016年10月14日星期五

Fuda Cancer Hospital Was Accredited by JCI

Fuda Cancer Hospital, based in Guangzhou, China, received a notice issued by the JCI headquarters on its gaining JCI accreditation, making it the 31st hospital in China that meets the standards designed by the world’s most stringent international hospital evaluation system.


                   Surveyors arriving at Fuda Cancer Hospital

Fuda Cancer Hospital embarked on the JCI accreditation journey in 2011. In the course of the past 2 years, all staff of Fuda Cancer Hospital worked closely together under correct hospital leadership and conducted every aspect of work following the JCI philosophy “To continuously improve the safety and quality of patient care”. From March 17 to 2014, Fuda Cancer Hospital received official inspections by JCI accreditation surveyors. And the hospital was eventually awarded the decision of Accreditation.
                  Survey opening conference and photograph taking

Winning JCI accreditation is a significant milestone in the development of Fuda Cancer hospital and marks a new starting point for the hospital. The hospital will incorporate the principle of continuously improving patient safety and care quality into its daily work, therefore enabling better delivery of higher-quality professional medical services for patients from at home and abroad under the precondition of safety assurance.

Morning meeting

The JCI headquarters notified Fuda of winning JCI accreditation and expressed congratulations. In his congratulation, the surveyor mentioned “Many thanks to your excellent team for giving me an opportunity to be educated and learn”.

Surveyors visiting the nurse station

It is reported that a total of 31 medical institutions have gained JCI accreditation in China. Of the 31 organizations, six are located in Guangdong province, with four in Guangzhou and two in Shenzhen. Fuda Cancer Hospital is the first privately owned specialty hospital in Guangzhou accredited by the JCI. There are over 1200 JCI measurable elements. If a hospital has more than 40 items that fail to meet the specified requirements, the accreditation is denied to the hospital.

                                         Facility tour and document review
Leadership session


Exit conference
Submission of the evaluation report

Submission of the evaluation report
Successful completion of inspections




2016年10月13日星期四

Expert of Fuda Cancer Hospital Being Invited as Guest at Russian Conference on Cancer Treatment

                  Dr Mu Feng (L1) was invited asguest at the conference.

From October 7 to 8 in 2016, the Second Russian Seminar on Cancer Treatment and New Technology was held at Russian State Surgery Research Institute solemnly. Experts and scholars for China, Sweden, Britain, Austria, Italy, Hungary, etc. gathered at Moscow to attend this event.
This event was held by Russian State Surgery Research Institute. Vice president of Guangzhou Fuda Cancer Hospital Dr Mu Feng was invited to be a guest and deliver a speech on “Experience of 8000 Cases Cryosurgery for Cancer”.
Dr Mu Feng delivered a special report on “Experience of 8000 Cases Cryosurgery for Cancer” at the seminar. 

The experts had an in-depth and heated discussion on related topics about cryosurgery in the seminar. Italian expert C. Pusceddu and Russian experts introduced their research and experience in the field of cryosurgery for renal cancer, soft tissue sarcoma, etc. And Russian expert showed needle-type cryoprobe with liquid nitrogen that they recently invented.

Foreign experts quoted experience and pictures of FUDA in their reports many times.
Dr Mu Feng and president of Russian Society of Cryosurgery Alexander Zhao (Left)
Experts attending the event had a discussion.

Vice president Mu Feng pointed out that resection, chemotherapy and radiation therapy consisted of conventional treatments. With the development of imaging technique, prevailing intervention oncology is a great progress in fighting cancer. Interventional therapy has become the fourth main treatment besides surgery, chemotherapy and radiation therapy. For example, like modern cryosurgery that represented the freezing technique with argon and helium emerging in the late period of last century, it brought hope to the cancer patients who couldn’t have surgery.    
As a treatment, cryosurgery has been approved and applied in clinical cancer treatment widely in the world. Clinical research showed that cryosurgery has irreplaceable function compared with other treatments. Especially it could perform percutaneous treatment which guided by imaging. And it security to great vessel also makes it have extensive application. 

Cryosurgery not only brings benefit to terminal patients who couldn’t accept surgery, in treating early stage cancer, it also achieves the same effect of surgery, like liver cancer, renal cancer, prostate cancer and lung cancer. As for unresectable tumor, like surgery, cryosurgery can eliminate most of it.
Cryosurgery technique of China has a leading position in the world. There are about 20 thousand cases of cryosurgery in our country. Just a Guangzhou Fuda Cancer Hospital, the number of the cryosurgery cases for cancer is more than 10 thousand person-times, which ranking the first place in the world. So they accumulate abundant experience of cryosurgery for cancer.
Fuda Cancer Hospital firstly applied cryosurgery in central lung cancer, local progressive pancreatic cancer and giant liver cancer. It has been a world-renowned characteristic and attracted patients from five continents of the world. In treating pancreatic cancer, FUDA leads the world. In American medical retrieval system, one third of literatures of cryosurgery for pancreatic cancer are from Guangzhou Fuda Cancer Hospital.
As one of the units firstly introduced cryosurgery technique in China, Fuda Cancer Hospital successively received Special Contribution Award in International Cryosurgery by International Society of Cryosurgery, Excellent Contribution Award at International Conference on Interventional Oncology, Excellent Contribution Award at Symposium on Mini-invasively Cancer Treatment of China, etc.
It’s said that the Third Asian Conference on Cryosurgery would be held at Beijing on November 4. Experts of Fuda Cancer Hospital will introduce their research outcome and clinical experience at the conference.




2016年10月4日星期二

Thanks for your company in the way of fighting cancer

In the morning of September 25, Guangdong Provincial Light of Life Society of Cancer Rehabilitation held an award ceremony named “Thanks for Your Company” for celebrating the 24th anniversary of society’s establishment on Shiyigong Rongquan Theatre at Guangzhou.

The anniversary ceremony was co-organized by Guangzhou Fuda Cancer Hospital and other medical enterprises. Former secretary general of Red Cross Society of Guangdong Province Yang Rong’en, Guangzhou Fuda Cancer Hospital general manager Liu Jianguo participated in the ceremony and delivered speeches. Society awarded “5-year Anti-cancer Hero” to 238 members, “10-year Anti-cancer Hero” to 101 members and “15-year Anti-cancer Hero” to 50 members. Among them, there are 52 men who have fought against cancer for over 26 years.

Guangdong Provincial Light of Life Society of Cancer Rehabilitation has developed for 24 years. There are about 5 thousand members in the society now. The survival rate of members is more than 80%. Their members come from all parts of Guangdong, from all walks of life. In the way of fighting cancer, they never stop moving forward and prove that cancer is not equal with death with actions.

As Light of Life Society of Cancer Rehabilitation’s partner, Guangzhou Fuda Cancer Hospital has provided services like treatments, rehabilitation and experts’ consultation for cancer patients of the society. Chief president of Guangzhou Fuda Cancer Hospital and honorary chairman of Light of Life Society of Cancer Rehabilitaion Prof. Xu Kecheng especially sent his best blessings to the society.
General manager of Guangzhou Fuda Cancer Hospital Liu Jianguo gave speech on stage.

Three points of Guangzhou Fuda Cancer Hospital’s general manager Liu Jianguo’s feelings of Light of Life Society of Cancer Rehabilitation were expressed in his speech:

“The first feeling is moving. Light of Life (abbreviation of Light of Life Society of Cancer Rehabilitation) is a respectable non-profit organization with a large number of warm-hearted people who devote their time and energy to offering courage of beating cancer for cancer patients, which makes me moving.

The second is thanking. Light of Life Society has been established for 24 years. Thanks to the support and helps of government and all circles of the community, society can go further.

The third is gratitude. I’d like to express my gratitude to members of Light of Life Society’s trusts to staff of Guangzhou Fuda Cancer Hospital. FUDA will guard society members’ health as always.

On “Thanks for Your Company” award ceremony, all programs were performed by members of the society in person. Their wonderful performance won warm applauses from audiences. 

A performer of new members was diagnosed as nasopharyngeal cancer. Just after having chemotherapy, he made up his mind to go to the stage and perform Meeting in the Yurt. He loves singing, and his sonorous singing won applauses from all members. 

According to Aunt Zeng’s introduction, after learning that he has nasopharyngeal cancer, he often felt afraid and confused. Members of Light of Life Society of Cancer Rehabilitation talked to him actively and encouraged him to face up to cancer toughly with their own stories of fighting cancer. And they let him join the society and feel care and warm so that he could get the confidence of fighting cancer again.

Guangdong Provincial Light of Life Society of Cancer Rehabilitation Chairman Ms. Guo Lianyou expressed her vision of society’s development and said that the progress of Light of Life Society couldn’t be made without hard work and unselfish contribution of members. 

A lot of member who are having chemotherapy recently registered for this event actively when they heard about that Light of Life Society would hold it, which is moving.
Group photo of Light of Life Society of Cancer Rehabilitation’s 24th Anniversary 

CeremonyLight of Life Society awards heroes who have fighting against cancer for five years, ten years and fifteen years etc. every year. It provides a stage for them to show themselves and encourages new members and more cancer patients to fight cancer together. In the future, Light of Life Society will affect and influence more cancer patients.


The 9th China Heath Rankings was released: only winner of “Most Social Responsible Specialized Hospital of the Year”

On September 22, the most significant award ceremony in the field of medicine – “The 9th China Health Rankings Award Ceremony” was held at Shanghai.

The event was held by 39.net. More than 70 leaders from many large-scale hospitals in China, more than 120 medical experts, over 500 elites of pharmaceutical industry and over 60 media attended this event. The award ceremony released several prizes including “Person of the Year”, “Most Popular Three-A Hospital of China” and “Most Social Responsible Hospital of the Year” etc.
“Most Social Responsible Prize of the Year” were a series of prizes which including “Most Social Responsible Multinational Pharmaceutical Company of the Year”, “Most Social Responsible Public Pharmaceutical Company of the Year”, “Most Social Responsible Specialized Hospital of the Year” and “Most Social Responsible Charitable Activity” etc.
There were six pharmaceutical companies, a specialized hospital and a charitable activity winning the series of prizes. They are public-spirited. They work hard to create value and undertake social responsibility, which makes them set example of taking social responsibility in medicine in 2016.
Among them, Guangzhou Fuda Cancer Hospital was awarded the prize “Most Social Responsible Specialized Hospital of the Year”, which was the only specialized hospital winning the award over the country.
Zuo Jiansheng (R3), president of Guangzhou Fuda Medical Co., Ltd. received the award.

Zuo Jiansheng, president of Guangzhou Fuda Medical Co., Ltd said: “Being awarded the prize ‘Most Social Responsible Specialized Hospital of the Year’ is the greatest support and praise.”
How a social responsible hospital develops
At present, people’s general recognition to private hospital is low. From their point of view, it’s hard to connect “social responsibility” with “private hospital”.
However, Guangzhou Fuda Cancer Hospital is just a private specialized hospital. Thought it has developed for just 13 years, it sets many records in the industry. FUDA devotes to improve terminal cancer patient’s life quality and prolong their life. It broke the usual bad habit of accepting red packets from patients and their family. Accepting red pockets, brokerage, meals and gifts never happen at FUDA. And it has donated more than 18 million yuan in all kinds of charitable activities.  
“Since established, FUDA always makes effort to be responsible to society and shape new image of private hospital with excellent medical skills and noble medical ethics. Winning the prize ‘Most Social Responsible Specialized Hospital of the Year’ is the greatest support and praise to us.” President of Guangzhou Fuda Medical Co., Ltd. said. 
Holding on to integrity, facing up to challenge and continuing to make innovation are the key elements that made Fuda Hospital role model of undertaking social responsibility. 
Keyword 1: Integrity
What private hospital lacks is brand and trust from patient nowadays. Chief president Xu Kecheng hopes to develop a different hospital, branded and trustworthy hospital when he established Fuda Cancer Hospital. Integrity is the base of private hospital’s development. If company doesn’t hold to integrity, it’s just like chronic suicide.
General manager of Guangzhou Fuda Cancer Hospital Liu Jianguo pointed out that, as a private cancer specialized hospital, the brand of FUDA was not accumulated overnight but day by day.
★ Legal operation and paying taxes as required. From 2008 to 
2014, this private hospital has paid more than 200 million yuan in tax. Just in last year, it paid over 30 million yuan in tax, which made it became AAA taxpayer enterprise of Guangzhou.
★ Never forget public welfare thought it’s not public hospital. Guangzhou Fuda Cancer Hospital insists in devoting into social public welfare career and charitable activities. In Wenchuan earthquake in 2008, FUDA donated 9.5 million in cash, ranking the first place among medical organizations of Guangdong. And it also sent the first medical team from private hospital. In Ya’an earthquake in 2013, they donated 5 million yuan. They donated 2 million for injured children and their family in Tianjing explosive accident at August 12…
FUDA has eliminated about 5 million yuan medical fee of more than 400 poor patients with low income. Although it reduced little profit, it took responsibility for society and won social trust so that winning brand awareness and good reputation. 
★ To patients, FUDA holds on to “Three Nos” principle. No overtreatment, no excessive examination, no overmedication. FUDA charges with integrity. Meanwhile, FUDA sets strict regulation – Medical staff is prohibited accepting red pockets, brokerage and meals. Once accept patient’s red pocket or any gift, related person not only has to afford the patient’s entire medical fee, but also accepted punishment, even dismissal. 
At FUDA, noble medical ethics and excellent medical skills are listed as two essential requirements of hospital’s development. “Professional medical care, friendly patient services”, the hospital tenet is practiced in every detail, which winning trust from numerous patients at home and abroad. 
Keyword 2: Challenge
It’s a hospital with short history and a hospital that constantly creating life miracles. Under the leadership of chief president Xu Kecheng, medical teams have successfully challenged “incurable disease”: Gurli from Denmark, Lana from Saudi Abrabia, Liangliang and Airin from Malaysia, Mingzai and Bingbing etc. Cancer patients who were on the edge of life and death gain new life here one by one.
As such, it attracts patients from more than 80 countries to seek medical care here. FUDA also has developed from a small hospital with 20 ward beds to a medical group with two districts and over 400 ward beds.
Chief president Xu Kecheng stressed, “Hospital’s development depends on choosing different way that people can’t imagine. We should think about it. Things that others do not dare to do, we should spare no effort to do it. Facing up to challenges has been FUDA’s style. It’s sure that challenging the impossible is based on security kept by academic pursuit, professional and careful preparation. ”
On August 11, it successfully operated a Nanoknife surgery for an 89-year old Philippine patient with pancreas head tumor, which remarking the case of the oldest pancreatic cancer patient that accepted Nanoknife therapy. FUDA set a new record again in the world.

Keyword 3: Innovation

Guangzhou Fuda Cancer Hospital mainly accepts advanced cancer patients. Enhancing patient’s life quality and survival requires not only sincere services, but also real medical skills, the “hard power” of treating cancer.
Making innovation is the fundamental solution of hospital’s development. Therefore, FUDA sticks to develop hospital by technology since it established. And it gathers a group of experts and scholars at home and abroad to explore cancer treatment. FUDA firstly introduced advanced techniques like cryosurgery, Nanoknife therapy etc. in China, which remarking many firsts in the industry. 
More than ten thousand cases of cryosurgery for cancer treatment ranks the first in the world. Successful rates of treating pancreatic cancer, central lung cancer and giant liver cancer etc. rank first. It published the first work of cryosurgery Cryosurgery for Cancer (written by Xu Kecheng and Niu Lizhi) and the first work of New Techinique of Cancer Ablation -- Irreversible Electroporation (written by Xu Kecheng and Niu Lizhi).
As one of the units firstly introducing cryosurgery, FUDA won “Outstanding Contribution to World Cryosurgery Award” by International Society of Cryosurgery, “Outstanding Contribution Award” by World Conference on Interventional Oncology, “Outstanding Contribution Award” by China Academic Conference on Mini-invasive Cancer Treatment etc.  
In 2010, Fuda Cancer Hospital was elected as “National Clinical Key Department (Oncology Department)” among 5500 private hospital in China by Chinese Health Department. Meanwhile, FUDA was approved as “Clinical Key Department (Oncology Department) of Guangdong”.
Behind the series of firsts, there are persistent explorations to medical difficulty and philanthropic humanistic feelings of medical staff at Fuda Cancer Hospital, as well as the reflection of undertaking social responsibility.